A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis. Loteprednol Allergic Conjunctivitis Study Group

American Journal of Ophthalmology
S J DellJ F Howes

Abstract

To evaluate the efficacy and safety of loteprednol etabonate 0.5% as prophylactic treatment for the ocular signs and symptoms of seasonal allergic conjunctivitis. In this randomized, double-masked, placebo-controlled, parallel study, 293 adults with history of seasonal allergic conjunctivitis were treated with either loteprednol etabonate or vehicle (placebo) four times daily, beginning before the onset of the allergy season and continuing for 6 weeks. The primary efficacy measure was a primary composite score (sum of itching and bulbar conjunctival injection scores). Supportive efficacy measures were the investigator global assessment and a secondary composite score (sum of tearing, erythema, chemosis, and discomfort scores), all calculated during the 21-day peak pollen season. The proportion of patients who never developed moderate or severe signs and symptoms of allergy during the peak pollen season in the loteprednol etabonate treatment group was greater than that in the placebo group. For the primary composite score, this efficacy criterion was reached by 94% of patients (136/145) in the loteprednol etabonate group and 78% of patients (111/143) in the placebo group (P = .001). The magnitude of effect was similar for the in...Continue Reading

References

Mar 1, 1978·Archives of Ophthalmology·M E YablonskiB Becker
Jan 1, 1992·Documenta Ophthalmologica. Advances in Ophthalmology·W ParysM Janssens
Sep 26, 1968·The New England Journal of Medicine·M M Reidenberg, D T Lowenthal
Oct 1, 1984·Medicinal Research Reviews·N Bodor
Jan 1, 1993·International Ophthalmology Clinics·E L Stock, R B Pendleton
Jan 1, 1993·Journal of Ocular Pharmacology·J D BartlettJ F Howes

❮ Previous
Next ❯

Citations

Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·N Bodor
Oct 7, 2014·The Ocular Surface·Stephen C PflugfelderVictor L Perez
Dec 11, 2002·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Katrina L Schmid, Leisa M Schmid
Mar 15, 2002·Current Allergy and Asthma Reports·M Friedlaender
Apr 27, 2012·International Journal of Inflammation·Timothy L Comstock, Heleen H Decory
Jun 4, 2015·Current Medical Research and Opinion·Lian-Qun WuRui-Li Wei
Mar 18, 2016·Advances in Therapy·John D SheppardMegan E Cavet
Aug 20, 2014·Ophthalmology and Therapy·Lisa SchopfHongming Chen
Dec 12, 2000·The Journal of Allergy and Clinical Immunology·L Bielory
Dec 13, 2012·Journal of Cataract and Refractive Surgery·Stephen S Lane, Edward J Holland
Mar 10, 2010·Expert Opinion on Pharmacotherapy·Timothy L Comstock, Edward J Holland
Jan 11, 2017·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Gail TorkildsenFrancis S Mah
Jan 5, 2002·Journal of Receptor and Signal Transduction Research·N Bodor, P Buchwald
Dec 29, 1998·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·M AbelsonM George
Nov 4, 2010·Acta Ophthalmologica·Yi QinDorothy Shu Ping Fan
Mar 26, 2019·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Megan E CavetEric Phillips
Nov 11, 1999·Current Opinion in Pediatrics·L C Schneider, M R Lester
Aug 27, 2013·Current Opinion in Allergy and Clinical Immunology·Punchama Pacharn, Pakit Vichyanond
Sep 10, 2020·Drug Delivery and Translational Research·Sherif A GaballaHamdy Abdelkader
Dec 23, 1999·Medicinal Research Reviews·N Bodor, P Buchwald
Nov 2, 2019·European Journal of Ophthalmology·Mohammud G MuslehAnnegret H Dahlmann-Noor
Nov 10, 2011·Acta Ophthalmologica·Brett P BieloryLeonard Bielory
Nov 28, 2008·Chemical Reviews·M Omar F Khan, Henry J Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.